Skip to content
naulon
Not checkedNot checked for notices yet.

MONOJO Biotech

Abu-Zaid Mohammad Z.

Green Processing and Synthesis · 2013

doi:10.1515/gps-2013-0030 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Company overviewMONOJO was established in 2005 to become a leader company in biotechnology.The company now epitomises the new concept of the knowledge-based economy.MONOJO is dedicated on developing, manufacturing, and marketing its own safe and effective biotech innovations, such as, monoclonal antibodies for cancer diagnostics, cancer research, and other novel biopharmaceutical therapies to meet serious worldwide unmet needs and illnesses in the field of oncology, endocrinology, dermatology, gastroenterology, and infectious diseases.MONOJO also provides unique training courses in the biotech and medical fields for public universities, medical sectors, and those running applied scientific research.By 2009, MONOJO started to expand its biotech projects for more effective and efficient work by signing a MOU agreement with the Institute of Biotechnology of the University of Cambridge, UK, represented by its institute's director and member of MONOJO's Board of Directors and Scientific Advisor, Prof. Christopher Lowe for the purpose of collaboration in: -Facilitating experts and students from Cambridge Biotech Institute (UK) to share their expertise and knowledge.-Assisting MONOJO to increase its research capability through scientific visits and training for MONOJO staff either in-house or at the Cambridge Biotech Institute (UK).-Facilitating collaborative biotech research and projects between MONOJO and the University of Cambridge (UK).MONOJO is currently a member of the UK BioIndustry Association; the association has enhanced MONOJO's visibility, network, and relationships with business

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.